FAQs

Why did Abbott decide to acquire Exact Sciences?

Abbott and Exact Sciences share a purpose to help people live fuller lives through better health. Exact Sciences brings industry‑leading expertise in molecular oncology and early cancer detection, which complements Abbott’s global scale, scientific leadership, and broad diagnostics portfolio.

Together, we will expand access to advanced cancer testing, accelerate innovation, and enhance patient care around the world.

 Does anything change for customers with the acquisition?

We do not anticipate any near‑term changes for customers. Our priority is maintaining business continuity and ensuring the same high level of service.

 Will current products still be offered?

Yes, Exact Sciences’ current portfolio of products and services remains the same.

 Does this affect insurance coverage or billing?

There are no changes to insurance coverage, billing procedures, or financial support programs because of this transaction. Customers and patients should continue to follow the same steps they follow today.

Products and Solutions

Need Help?

© 2026 Abbott. All Rights Reserved. Please read the Legal Notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are approved for use in the U.S. only and are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.